Dubai Health and GE HealthCare to enhance Point-of-Care Ultrasound education and practice in the MENA region
Dubai, UAE: Dubai Health and GE HealthCare, a leading global medical technology and digital solutions innovator, have signed a Memorandum of Understanding (MoU) to collaborate on enhancing Point-of-Care Ultrasound (POCUS) practices and co-developing innovative AI solutions to support clinical decision-making, ultimately enhancing patient care and outcomes across the UAE and the Middle East and North Africa (MENA) region.
The collaboration combines Dubai Health's academic and innovation expertise with GE HealthCare's advanced technological capabilities to enhance medical education, strengthen clinical decision-making, and improve health outcomes throughout the UAE and the broader MENA region.
The MoU will establish Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) as a POCUS Education Center of Excellence and a pioneer in Point-of-Care Ultrasound education across the MENA region.
Key initiatives include: a 'Train-of-Trainer (TOT)' structured program to build capacity in certified facilitators and trainers. The Facilitator Training Program will also enhance the scalability and effectiveness of POCUS program delivery and execution across a broader geographical region, enabling wider participation of attendees, students, and delegates.
In addition, the collaboration will extend to the co-development of AI solutions through Dubai Health Innovations, which supports transformative solutions that enhance patient care, drive medical advancements, and improve health outcomes. This partnership will focus on the development and validation of emerging AI technologies in areas of mutual interest, such as radiology and computer vision, aiming to improve diagnostic accuracy, streamline clinical workflows, and facilitate early detection of medical conditions. Through this joint effort, both parties seek to foster innovation, accelerate adoption of cutting-edge AI tools, and contribute to the advancement of healthcare delivery in the region.
Dr. Hanan Al Suwaidi, Acting Chief Academic Officer of Dubai Health and Provost of MBRU said: 'This collaboration reflects Dubai Health's commitment to delivering on our 'Patient First' promise through the integration of care, learning, and innovation to elevate healthcare standards. By building capacity in POCUS education and co-developing AI-powered solutions, we are empowering clinicians with next-generation technologies to improve patient outcomes.'
President of GE HealthCare EAGM (Eurasian and African Growth Markets), Konstantinos Deligiannis, said: 'This MoU marks a pivotal moment for POCUS advancement in the MENA region. We are excited to partner with Dubai Health to build skills, accelerate knowledge transfer, and strengthen the local and regional healthcare expertise. By combining our advanced ultrasound technology with innovative AI solutions, we are committed to enhancing diagnostic accuracy and efficiency, ultimately contributing to the region's broader healthcare objectives.'
Dr. Rasha Buhumaid, Vice Dean of Graduate Medical Education, Assistant Professor of Emergency Medicine, and Program Director of POCUS at MBRU, further commented: 'This partnership is a significant step toward realizing our vision of positioning MBRU as a Center of Excellence for Point-of-Care Ultrasound education. Through the Facilitator Training Program and other initiatives, this collaboration enables us to strengthen the integration of POCUS into clinical practice, build sustainable expertise, and support better outcomes at the point of care and across the health system.'
Professor Nabil Zary, Senior Director of the Institute of Learning at Dubai Health, also noted: 'Education is at the heart of sustainable healthcare transformation. This partnership with GE HealthCare enables us to deliver high-impact, evidence-based training in POCUS that not only equips clinicians with advanced skills but also fosters a culture of continuous learning and innovation.'
The MoU between the two parties will be in effect for two years and is renewable by mutual agreement.
About Dubai Health
Dubai Health, the first integrated academic health system in Dubai, was established to elevate the standard of care and to advance health for humanity. Dubai Health is comprised of 6 hospitals, 26 ambulatory health centers, 21 medical fitness centers, Mohammed Bin Rashid University of Medicine and Health Sciences, and Al Jalila Foundation. Together, Dubai Health serves patients through the integration of care, learning, discovery, and giving. A workforce of over 11,000 collaborates across multidisciplinary teams to put the patient first.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient's journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
2 hours ago
- The National
UAE and Jordan conduct new air drops to Gaza as Emirati aid convoy arrives
The UAE and Jordan air dropped critical aid into the Gaza Strip for a fourth day on Wednesday as an Emirati convoy of 58 lorries brought more humanitarian supplies into the enclave. Jordan's Petra news agency said the airdrops were carried out by two C-130 Royal Jordanian Air Force planes and an Emirati counterpart. It added that 16 tonnes of food and baby formula were delivered to various areas of Gaza Strip, bringing the total cargo dropped over the past few days to about 73 tonnes of essential supplies. The fleet of lorries arrived in Gaza through border crossings to support broader relief operations in support of Palestinians, state news agency Wam reported. Meanwhile, Belgium will take part in a multicountry operation in co-ordination with Jordan to air drop aid to Gaza, Brussels has announced, as UN agencies warn the Palestinian territory is slipping into famine. A Belgian aircraft carrying medical supplies and food worth €600,000 ($690,000) will "soon" fly to Jordan and remain on stand-by to conduct air drops, said the defence and foreign ministries in Brussels. Gaza's hospitals have recorded seven new deaths from malnutrition and starvation in the past 24 hours, the Health Ministry said. This takes the death toll from starvation during the conflict to 154 – including 89 children – the ministry said. At least 60,138 Palestinians have been killed and 146,269 wounded since the Gaza war began, the ministry said.
Zawya
4 hours ago
- Zawya
Saudi foodtech startup secures $39mln funding round for global expansion plans
Riyadh - Calo, the Middle East's largest foodtech startup, has raised $39 million (SAR 146.27 million) in a series B extension round, bringing the total funding to $64 million (SAR 240 million). Led by AlJazira Capital, Oraseya Capital, Nuwa Capital, STV, Khwarizmi Ventures, and Al Faisaliah Group, the transaction follows an initial $25 million tranche secured in December 2024, according to a press release. The oversubscribed round supports Calo's global expansion plans, integration of recent UK acquisitions, and continued investment in AI-powered personalized nutrition. The CEO and Co-Founder of Calo, Ahmed Al Rawi, commented: 'We're living in an interesting time where AI is transforming our lives, and we're excited to be investing in cutting-edge innovation to explore how Calo can use AI to influence the future of how we discover and eat healthy food.' He added: 'Being vertically integrated with the mission of 'Making Healthy Easy' gives us an edge to develop and scale world-class experiences not just regionally, but also globally.' Calo recently acquired UK-based meal subscription brands Fresh Fitness Food and Detox Kitchen, integrating them into its operations and marking the company's entry into the European market. The company, which now operates more than 10 physical locations across the GCC, grew over 50% year-on-year (YoY) in the first half (H1) of 2025. Calo is piloting Calo Black, an AI-powered private chef experience that uses large language models (LLMs) to understand individual customer preferences through natural conversation and craft personalized daily menus. It is worth noting that Calo partnered with premium gym operator Armah Sports Company to expand wellness and retail offerings through co-located outlets, cross-promotions, and product distribution across gym networks. Riyadh-headquartered Calo operates in Saudi Arabia, the UAE, Bahrain, Qatar, and Kuwait, with expansion now underway in the UK.
Web Release
4 hours ago
- Web Release
Gulf Capital Successfully Exits ART Fertility Clinics' Middle East Operations Selling Its Stake to IVI-RMA Global, World Leader in Fertility and Assisted Reproduction.
Gulf Capital, one of the largest private equity firms investing from the GCC to the rest of Asia, announced today that it has sold its majority stake in ART Fertility Clinics' Middle East operations to IVI-RMA Global, the world's largest assisted reproduction group. The transaction is expected to generate a significant return on invested capital, making it one of Gulf Capital's most successful exits to date. Since its acquisition in 2020, ART Fertility Clinics has undergone a period of significant growth and transformation. Under Gulf Capital's ownership, ART expanded from a UAE-focused business into a regional fertility platform with 15 clinics, including 3 in the UAE, 1 in Saudi, and 11 in India. The scope of the transaction includes the clinics located in UAE and Saudi Arabia, while the India operation will remain under the ownership of Gulf Capital. In the Middle East alone, ART Fertility Clinics has delivered substantial revenue and EBITDA growth since 2020, with profitability quadrupling over the last five years. This strong financial performance has been underpinned by ART's reputation for clinical excellence, rapid regional expansion and some of the highest success rates in IVF treatments across the region. Dr. Karim El Solh, Co-Founder and CEO of Gulf Capital, commented: 'We are proud of the transformation we achieved at ART Fertility, scaling the platform from a single-country operator to the regional leader in reproductive medicine. Under Gulf Capital's ownership, ART Fertility invested heavily in science and research with 220 medical publications to date and launched a pioneering genetic testing lab in Abu Dhabi, leading to some of the highest IVF fertility success rates globally. ART Fertility's expansion and financial performance underline Gulf Capital's deep focus on operational improvements and growth. Following a competitive auction, the successful sale of the company to a global strategic buyer highlights Gulf Capital's ability to source, grow and exit healthcare platforms at very attractive multiples.' Suresh Soni, CEO of ART Fertility Clinics, said: 'ART Fertility has built a strong reputation for clinical excellence and world-class patient outcomes. Our success has been driven by our scientific rigor, a world-renowned medical team led by Prof. Dr Human Fatemi, and a deep commitment to providing the best-in-class care. With the support of Gulf Capital, we were able to expand successfully across the region and enhance our service offerings including adding in house genetic capabilities. We are excited to join IVI-RMA's global platform and to continue delivering on our mission and commitment towards the GCC community.' Hazem Abu Khalaf, Managing Director and Head of Healthcare investments at Gulf Capital, added: 'Our investment in ART Fertility is a clear example of Gulf Capital's ability to drive operational improvement and strategic growth in high-impact sectors. As one of the most vital and fast-evolving industries in the GCC, healthcare continues to offer both meaningful impact and long-term growth opportunities. ART Fertility stands as a testament to that potential. Over the past few years, we have helped build a business that combines scale, profitability, and clinical leadership – three elements that are often difficult to align. We are confident that ART Fertility is well-positioned for continued success in its next phase of growth under IVI-RMA's ownership and proud to have laid the foundation for its continued success in advancing specialized healthcare in the region' Gulf Capital and ART Fertility Clinics were advised by Moelis & Company as M&A advisor, and A&O Shearman as legal advisor on the transaction.
